Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL35

FUROSEMIDE
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl

Basic Information

ChEMBL ID CHEMBL35
Name FUROSEMIDE
Phase Approved
Structure Type MOL
InChI Key ZZUFCTLCJUWOSV-UHFFFAOYSA-N
Therapeutic ✓ Yes

Known Names

Aluzine 20 Aluzine 40 Aluzine 500 Aquamed Diuresal Dryptal Froop Frumax Frumil Frusemide Frusetic Frusid +16 more
23
Targets
36
Activities
4
Assay Types
30
PK Parameters
20
Publications
28
Known Names
20
Indications
1
Mechanisms

Molecular Properties

330.8
MW (Da)
1.89
ALogP
5
HBA
3
HBD
122.6
PSA (Ų)
0.77
QED
0
Ro5 Violations
5
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 1966
Availability Prescription
Chirality Achiral

Routes of Administration

Oral Parenteral

Flags

Black Box Warning Natural Product
USAN Stem -semide
USAN Year 1964

Extended Properties

Molecular Formula C12H11ClN2O5S
MW 330.75
Aromatic Rings 2
Heavy Atoms 21
NP-Likeness -1.77

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Sodium-(potassium)-chloride cotransporter 2 inhibitor INHIBITOR Solute carrier family 12 member 1

Indications

Cardiovascular Diseases Fibrosis Heart Failure Heart Failure Hypertension Liver Cirrhosis Nephrotic Syndrome Pulmonary Edema Syndrome Atherosclerosis Bronchiolitis Coronary Disease Diabetes Mellitus, Type 2 Essential Hypertension Hypercholesterolemia Kidney Calculi Kidney Diseases Lung Diseases Myocardial Infarction Pre-Eclampsia

ATC Classification

C03CA01
furosemide
Level 1: CARDIOVASCULAR SYSTEM
Level 2: DIURETICS

Drug Warnings

Black Box Warning
General Warning
Country: United States

Activity Summary

Ki 18 meas. best 7.28
IC50 13 meas. best 7.1
Kd 3 meas. best 6.2
EC50 2 meas. best 5.21

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Carbonic anhydrase 14
CHEMBL3510
Ki 7.28 7.28 52.0 1
Carbonic anhydrase 1
CHEMBL261
Ki 7.21 7.21 62.0 1
Carbonic anhydrase 2
CHEMBL205
Ki 7.19 7.19 65.0 1
Carbonic anhydrase 1
CHEMBL261
IC50 7.1 7.1 80.0 1
Carbonic anhydrase 6
CHEMBL3025
Ki 6.61 6.61 245.0 1
Carbonic anhydrase 12
CHEMBL3242
Ki 6.58 6.58 261.0 1
Carbonic anhydrase 5B, mitochondrial
CHEMBL3969
Ki 6.49 6.49 322.0 1
Carbonic anhydrase 9
CHEMBL3594
Ki 6.38 6.38 420.0 1
Carbonic anhydrase 5A, mitochondrial
CHEMBL4789
Ki 6.3 6.3 499.0 1
Carbonic anhydrase 7
CHEMBL2326
Ki 6.29 6.29 513.0 1
Carbonic anhydrase 13
CHEMBL2186
Ki 6.26 6.26 550.0 1
Carbonic anhydrase 4
CHEMBL3729
Ki 6.25 6.25 564.0 1
Carbonic anhydrase 2
CHEMBL205
Kd 6.2 5.85 630.0 2
CDGSH iron-sulfur domain-containing protein 1
CHEMBL1795168
Ki 5.64 5.64 2285.0 1
Broad substrate specificity ATP-binding cassette transporter ABCG2
CHEMBL5393
IC50 5.5 5.5 3200.0 1
G-protein coupled receptor 35
CHEMBL1293267
Ki 5.49 5.49 3270.0 1
11-beta-hydroxysteroid dehydrogenase 1
CHEMBL3910
IC50 5.42 5.42 3760.0 1
11-beta-hydroxysteroid dehydrogenase 1
CHEMBL4235
IC50 5.42 5.42 3760.0 1
G-protein coupled receptor 35
CHEMBL1293267
EC50 5.21 5.08 6200.0 2
Solute carrier family 22 member 6
CHEMBL1777665
Ki 5.02 5.02 9500.0 1
Aquaporin-4
CHEMBL5291512
IC50 5.0 5.0 10000.0 1
Felis catus
CHEMBL612670
IC50 5.0 5.0 10000.0 1
Plasmodium falciparum
CHEMBL364
IC50 4.9 4.8667 12589.2 3
Holo-[acyl-carrier-protein] synthase
CHEMBL4734
IC50 4.9 4.9 12700.0 1
Hepatic sodium/bile acid cotransporter
CHEMBL5287
IC50 4.82 4.82 15000.0 1
Solute carrier organic anion transporter family member 2A1
CHEMBL2073680
Ki 4.33 4.33 47000.0 1
CDGSH iron-sulfur domain-containing protein 1
CHEMBL1795168
Kd 4.28 4.28 53000.0 1
CDGSH iron-sulfur domain-containing protein 1
CHEMBL1795168
IC50 4.27 4.27 53460.0 1

Pharmacokinetic Data

Parameter Value Units Species
CL 0.59 mL.min-1.kg-1 Homo sapiens
CL 2.4 mL.min-1.kg-1 Homo sapiens
CL 2.4 mL.min-1.kg-1 Homo sapiens
CL 0.7 mL.min-1.kg-1 Homo sapiens
CL - - Rattus norvegicus
CL - - Rattus norvegicus
CL 1.6 mL.min-1.kg-1 Homo sapiens
CL 2.0 mL.min-1.kg-1 Homo sapiens
CL 2.9 mL.min-1.kg-1 Macaca
CL 4.8 mL.min-1.kg-1 Rattus norvegicus
CL 12.0 mL.min-1.kg-1 Canis lupus familiaris
CL 6.31 mL.min-1.g-1 Homo sapiens
CL 3.0 uL.min-1.(10^6cells)-1 Homo sapiens
CL 7.2e-05 mL.min-1.g-1 Homo sapiens
CL - - Homo sapiens
CL 84.9 mL.min-1.kg-1 Homo sapiens
CL 0.99 uL.min-1.(10^6cells)-1 Homo sapiens
CL 2.12 mL.min-1.kg-1 Homo sapiens
CL 1.6 mL.min-1.kg-1 Homo sapiens
CL 1.7 mL.min-1.kg-1 Homo sapiens
CL 0.072 uL/min Homo sapiens
Cmax 18100.0 nM Homo sapiens
F 79.0 % Homo sapiens
F 40.0 % Homo sapiens
F 64.0 % Homo sapiens
F 60.0 % Homo sapiens
Fu 0.012 - Homo sapiens
Fu 0.012 - Homo sapiens
Fu 0.091 - Mus musculus
Fu 0.048 - Canis lupus familiaris

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Carbonic anhydrase 14 Ki = 52.0 nM 7.28 Inhibition of human recombinant full length CA14 by stopped-flow CO2 hydration m... 19119014
Carbonic anhydrase 1 Ki = 62.0 nM 7.21 Inhibition of human recombinant full length CA1 by stopped-flow CO2 hydration me... 19119014
Carbonic anhydrase 2 Ki = 65.0 nM 7.19 Inhibition of human recombinant full length CA2 by stopped-flow CO2 hydration me... 19119014
Carbonic anhydrase 1 IC50 = 80.0 nM 7.1 Known Inhibitors of Carbonic Anhydrase: Compounds which are CAIs are well known ... -
Carbonic anhydrase 6 Ki = 245.0 nM 6.61 Inhibition of human recombinant full length CA6 by stopped-flow CO2 hydration me... 19119014
Carbonic anhydrase 12 Ki = 261.0 nM 6.58 Inhibition of human recombinant CA12 catalytic domain by stopped-flow CO2 hydrat... 19119014
Carbonic anhydrase 5B, mitochondrial Ki = 322.0 nM 6.49 Inhibition of human recombinant full length CA5B by stopped-flow CO2 hydration m... 19119014
Carbonic anhydrase 9 Ki = 420.0 nM 6.38 Inhibition of human recombinant CA9 catalytic domain by stopped-flow CO2 hydrati... 19119014
Carbonic anhydrase 5A, mitochondrial Ki = 499.0 nM 6.3 Inhibition of human recombinant full length CA5A by stopped-flow CO2 hydration m... 19119014
Carbonic anhydrase 7 Ki = 513.0 nM 6.29 Inhibition of human recombinant full length CA7 by stopped-flow CO2 hydration me... 19119014
Carbonic anhydrase 13 Ki = 550.0 nM 6.26 Inhibition of mouse recombinant full length CA13 by stopped-flow CO2 hydration m... 19119014
Carbonic anhydrase 4 Ki = 564.0 nM 6.25 Inhibition of human recombinant full length CA4 by stopped-flow CO2 hydration me... 19119014
Carbonic anhydrase 2 Kd = 630.0 nM 6.2 Binding affinity to human recombinant CA II assessed as dissociation constant 39161321
CDGSH iron-sulfur domain-containing protein 1 Ki = 2285.0 nM 5.64 Displacement of [3H]rosiglitazone from recombinant human C-terminal His-tagged M... 27687671
Broad substrate specificity ATP-binding cassette transporter ABCG2 IC50 = 3200.0 nM 5.5 Inhibition of ABCG2 (unknown origin) expressed in human HEK293-A cells membrane ... 35483322
Carbonic anhydrase 2 Kd = 3140.0 nM 5.5 Displacement of dansylamide from human recombinant CA II expressed in Escherichi... 39161321
G-protein coupled receptor 35 Ki = 3270.0 nM 5.49 Displacement of [3H]PSB-13253 from human recombinant GPR35 exprssed in CHO cells... 23888932
11-beta-hydroxysteroid dehydrogenase 1 IC50 = 3760.0 nM 5.42 Inhibition of mouse 11beta-HSD1 expressed in HEK293 cells assessed as conversion... 18653260
11-beta-hydroxysteroid dehydrogenase 1 IC50 = 3760.0 nM 5.42 Inhibition of human 11beta-HSD1 expressed in HEK293 cells assessed as conversion... 18653260
G-protein coupled receptor 35 EC50 = 6200.0 nM 5.21 Agonist activity at human GPR35 by Ca+2 release assay 23888932

Literature References

PubMed DOI Target Context # Activities
- 10.6019/CHEMBL3885861 Rattus norvegicus 1415
- 10.6019/CHEMBL3885881 Rattus norvegicus 295
- 10.1101/2024.03.28.586928 ADMET 100
1433206 10.1021/jm00100a001 Rattus norvegicus 46
7966129 10.1021/jm00048a005 Rattus norvegicus 25
2724291 10.1021/jm00126a003 Rattus norvegicus 22
21051535 10.1124/dmd.110.034629 ADMET 21
1501234 10.1021/jm00094a022 Rattus norvegicus 19
16472241 10.2174/1570163043334794 Hepatotoxicity 18
3712385 10.1021/jm00156a011 Rattus norvegicus 18
- 10.1007/s00044-012-0086-y Rattus norvegicus 16
7452697 10.1021/jm00186a024 Rattus norvegicus 14
22194678 10.1371/journal.pcbi.1002310 Hepatotoxicity 14
19361209 10.1021/jm900025h Rattus norvegicus 12
6737427 10.1021/jm00373a005 Rattus norvegicus 12
3735318 10.1021/jm00158a030 ADMET 12
15646539 10.1016/s0399-8320(04)95062-2 Unchecked 11
7205867 10.1021/jm00133a024 Rattus norvegicus 10
7966129 10.1021/jm00048a005 Canis familiaris 10
6876086 10.1021/jm00362a017 Canis familiaris 10

Data from ChEMBL 36 via Core Engine